ALLMedicine™ Hepatitis D Center
Research & Reviews 549 results
https://doi.org/10.1111/jvh.13490
Journal of Viral Hepatitis; Cheng D, Han B et. al.
Feb 18th, 2021 - With extensive research on the pathogenesis and treatment of hepatitis B virus (HBV) and hepatitis D virus (HDV) infections, the current treatment of interferon and nucleoside or nucleotide analogues provides reasonable control of viral replicatio...
https://doi.org/10.1007/s40265-020-01464-z 10.1080/19491034.2018.1460045 10.1111/acel.12979 10.1021/acsomega.9b02263 10.1073/pnas.0506001102 10.1194/jlr.R500012-JLR200 10.18632/oncotarget.19363 10.1124/dmd.105.007906 10.1161/CIRCULATIONAHA.113.008285 10.1073/pnas.1202529109 10.1212/WNL.0b013e31829d85c0 10.1016/S1473-3099(15)00074-2 10.1002/hep.29658 10.1016/S0168-8278(18)30397-0 10.1016/S0168-8278(20)30774-1
Drugs Dhillon S
Feb 16th, 2021 - Lonafarnib (Zokinvy™) is an orally active farnesyltransferase inhibitor developed by Eiger BioPharmaceuticals under license from Merck & Co. for the treatment of hepatitis D virus (HDV) infections, and progeria and progeroid laminopathies. The dru...
https://doi.org/10.1016/j.jhep.2021.01.014
Journal of Hepatology; Rizzetto M, Hamid S et. al.
Jan 23rd, 2021 - The global scenario of hepatitis D is changing with the widespread implementation of vaccination against hepatitis B. In high-income countries that achieved optimal control of HBV, the epidemiology of hepatitis D is dual, consisting of an ageing c...
https://doi.org/10.1016/j.antiviral.2020.104995
Antiviral Research; Abdrakhman A, Ashimkhanova A et. al.
Dec 15th, 2020 - Chronic HDV infection often is associated with aggressive form of liver disease, compared to chronic HBV mono-infection. However, chronic HDV treatment is challenging because currently there is no approved regimen for affected patients. While stan...
https://doi.org/10.1016/j.jhep.2020.11.032
Journal of Hepatology; Zhang Z, Urban S
Dec 4th, 2020 - Chronic hepatitis D (CHD), a global health problem, manifests as the most severe form of viral hepatitis. The causative agent, HDV, is the smallest known human virus; it replicates its circular single-stranded RNA genome in the nucleus of hepatocy...
Clinicaltrials.gov 579 results
https://doi.org/10.1111/jvh.13490
Journal of Viral Hepatitis; Cheng D, Han B et. al.
Feb 18th, 2021 - With extensive research on the pathogenesis and treatment of hepatitis B virus (HBV) and hepatitis D virus (HDV) infections, the current treatment of interferon and nucleoside or nucleotide analogues provides reasonable control of viral replicatio...
https://doi.org/10.1007/s40265-020-01464-z 10.1080/19491034.2018.1460045 10.1111/acel.12979 10.1021/acsomega.9b02263 10.1073/pnas.0506001102 10.1194/jlr.R500012-JLR200 10.18632/oncotarget.19363 10.1124/dmd.105.007906 10.1161/CIRCULATIONAHA.113.008285 10.1073/pnas.1202529109 10.1212/WNL.0b013e31829d85c0 10.1016/S1473-3099(15)00074-2 10.1002/hep.29658 10.1016/S0168-8278(18)30397-0 10.1016/S0168-8278(20)30774-1
Drugs Dhillon S
Feb 16th, 2021 - Lonafarnib (Zokinvy™) is an orally active farnesyltransferase inhibitor developed by Eiger BioPharmaceuticals under license from Merck & Co. for the treatment of hepatitis D virus (HDV) infections, and progeria and progeroid laminopathies. The dru...
https://doi.org/10.1016/j.jhep.2021.01.014
Journal of Hepatology; Rizzetto M, Hamid S et. al.
Jan 23rd, 2021 - The global scenario of hepatitis D is changing with the widespread implementation of vaccination against hepatitis B. In high-income countries that achieved optimal control of HBV, the epidemiology of hepatitis D is dual, consisting of an ageing c...
https://doi.org/10.1016/j.antiviral.2020.104995
Antiviral Research; Abdrakhman A, Ashimkhanova A et. al.
Dec 15th, 2020 - Chronic HDV infection often is associated with aggressive form of liver disease, compared to chronic HBV mono-infection. However, chronic HDV treatment is challenging because currently there is no approved regimen for affected patients. While stan...
https://doi.org/10.1016/j.jhep.2020.11.032
Journal of Hepatology; Zhang Z, Urban S
Dec 4th, 2020 - Chronic hepatitis D (CHD), a global health problem, manifests as the most severe form of viral hepatitis. The causative agent, HDV, is the smallest known human virus; it replicates its circular single-stranded RNA genome in the nucleus of hepatocy...
News 27 results
https://www.medscape.com/viewarticle/940855
Nov 12th, 2020 - NEW YORK (Reuters Health) - Several risk factors associated with hepatitis D virus (HDV) infection can be used to identify people who should be screened, researchers report. "It was interesting to find that the risk factors that were identified in...
https://www.medscape.com/viewarticle/922853
Dec 19th, 2019 - NEW YORK (Reuters Health) - Hepatitis delta virus (HDV) infection, which occurs only as a co-infection with acute hepatitis B (HBV) or a superinfection with chronic HBV, is associated with higher healthcare utilization and costs than HBV alone, a ...
https://www.mdedge.com/gihepnews/article/211868/hepatology/hdv-combo-therapy-reduces-viral-loads?channel=346
Will Pass, MDedge News
Nov 8th, 2019 - BOSTON – For most patients with chronic hepatitis D virus (HDV) infection, combination therapy with lonafarnib, ritonavir, and peginterferon may significantly decrease viral loads, based on interim results from the phase IIa LIFT trial. After 6 mo.
https://www.medscape.com/viewarticle/895006
Apr 19th, 2018 - What is the hepatitis virus? Well, the hepatitis virus invades liver cells and causes inflammation in the liver tissue. Five hepatitis viruses are recognized: hepatitis A, hepatitis B, hepatitis C, hepatitis D, and hepatitis E. They all have sligh...
https://www.mdedge.com/ccjm/article/110841/hepatology/reply-acute-liver-failure?channel=164
Tavankit Singh, MD, Nancy Gupta, MD et. al.
Aug 1st, 2016 - In Reply: We thank Dr. Homler for bringing hepatitis D as a potential cause of acute liver failure to our attention.